Skip to content

State coverage

Georgia Medicaid and GLP-1 coverage

State Medicaid · 6 documents cited

Medicaid, for obesity: Does not cover. The conditions and the appeal deadline are in the summary below.

At a glance

Does not cover
Medicaid, for obesity
Weight-loss agents are a named exclusion. The one open door is Saxenda for ages 12 to 17, and it shuts at 18.
Appeal deadline
30 days from the date on the adverse action letter source
Date read
August 2026

Georgia's answer is old, stable and easy to read, which makes it unusual. Its pharmacy manual carries the federal list of drug categories a state may leave out, and the first entry on that list is agents used for anorexia, weight loss or weight gain. Nothing recent changed it, so there is no bulletin here to cite and no reversal to explain.

The interesting part is the exception, because it is not the one you would predict. Georgia does cover two weight-related drugs, Xenical and Saxenda, and it covers them only for children and teenagers. Its own criteria say so in a single sentence: they are not covered for anyone under 12 or for anyone 18 or over. Saxenda is a GLP-1, so Georgia is a state where this class of drug is available for a weight-related reason at 17 and unavailable at 18.

Everything else in the class runs through diabetes. Every approval route in Georgia's criteria for these drugs turns on a type 2 diabetes diagnosis, and the words obesity and weight are not in that document at all. Wegovy and Zepbound are on neither version of the August 1, 2026 drug list, though Ozempic and Saxenda are. Georgia says the list does not name every drug it covers, so treat that as what the list shows rather than the final word.

One caution. Nothing Georgia publishes says its managed care plans have to use the state's list. Every criteria document here is headed for fee-for-service, and the pharmacy manual tells prescribers to ask each plan separately and names three different plan pharmacy administrators. So read what follows as the fee-for-service position and check your own plan's list before you count on it.

What we could verify for Georgia

Georgia's pharmacy manual names the exclusion. It says that "As provided by Section 1927(d)(2) of the Act, certain outpatient drugs may be excluded from coverage. Those excluded are:" and the first item under that is "Agents used for anorexia, weight loss or weight gain." This is a category, not a decision about any particular product.

Georgia Department of Community Health, Part II Policies and Procedures for Pharmacy Services, effective July 2026 · source

There is one door and it is age-limited. Georgia's criteria state: "NOTE: Xenical and Saxenda are not covered for members younger than 12 years of age or for members 18 years of age and older and requires prior authorization for members 12 to 17 years of age." For a teenager who qualifies, Saxenda is "Approvable for members 12 to 17 years of age with a diagnosis of hypercholesterolemia or hyperlipidemia who are currently taking lipid-lowering medications, who weigh greater than 60 kg and who have an initial body mass index (BMI) of 30 kg/m2 or greater," used "as an adjunct to a reduced-calorie diet and increased physical activity," and only after an inadequate response, allergy, contraindication or intolerable side effect with Xenical. Authorization runs one year. ⚠ This document prints one date, "Revised 07/09/2021," and it is the version the state's own criteria index links today.

Georgia Medicaid Fee-for-Service, Antihyperlipidemics Other Prior Authorization Summary, effective July 2021 · source

Every other GLP-1 in Georgia is a diabetes drug. The state's antidiabetic criteria approve Ozempic, for instance, "for members 18 years of age or older with a diagnosis of type 2 diabetes mellitus (T2DM) whose HbA1c level is 6.5% or higher when the requested medication is being used to improve glycemic control." We searched that document for the words obesity and weight and found neither anywhere in it, while type 2 diabetes mellitus appears throughout.

Georgia Medicaid Fee-for-Service, Antidiabetic Agents Prior Authorization Summary, effective July 2026 · source

Wegovy and Zepbound are on neither version of Georgia's August 1, 2026 drug list — not the one arranged by class, nor the one arranged by drug name — while Ozempic and Saxenda are on both, so they are absent from the list rather than from our reading of it. Mounjaro, Ozempic and Victoza are listed preferred with prior authorization and quantity limits under "MISC. ANTIDIABETIC AGENTS"; Saxenda is listed non-preferred with "PA (12 yrs-17 yrs)" and Xenical as "XENICAL (covered 12 - 17 yrs old)." The list carries its own warning, which is why this is what the list shows rather than the last word: "This list does not include all drugs covered under the Georgia Medicaid/PeachCare for Kids outpatient pharmacy program."

Georgia Department of Community Health, Georgia Medicaid and PeachCare Preferred Drug List, effective August 2026 · source

Georgia does publish one obesity pathway, and it is for a rare genetic condition rather than for obesity generally. Setmelanotide is "Approvable for members 2 to 17 years of age with a diagnosis of syndromic or monogenic obesity in the 95th percentile of the member's weight using growth chart assessments or members 18 years of age or older with a diagnosis of syndromic or monogenic obesity with a body mass index (BMI) of 30 kg/m2 or greater who have proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1) or leptin receptor (LEPR) deficiency," with a parallel route for Bardet-Biedl syndrome. It is listed non-preferred.

Georgia Medicaid Fee-for-Service, Imcivree Prior Authorization Summary, effective January 2026 · source

Georgia gives you 30 days and counts them from the letter, not from when it reached you. Its manual says: "A hearing must be requested either in writing or by email. The hearing request and a copy of the adverse action letter must be received by the Department within 30 days or less from the date of the adverse action letter." You can keep your medicine meanwhile — "Members may continue their services during the appeal if they submit a written request for continued services before the date that the services change." Two limits: the section says "This section does not apply to PeachCare for Kids members," and it does not say whether a Georgia Families plan appeal has to finish first, so ask your plan.

Georgia Department of Community Health, Part I Policies and Procedures for Medicaid and PeachCare for Kids, effective July 2026 · source

Georgia is one of 6 states whose Medicaid gives the same answer: weight loss excluded, and no other route named. Georgia Medicaid's rule doesn't reach a job-based plan or Medicare. If you have one of those, read employer plans or Medicare Part D instead, and compare Georgia with the rest in the coverage matrix.

Regional insurers that sell plans in Georgia and have their own page here, quoted from their own policy documents: Kaiser Permanente Georgia. The national insurers are on the insurance index.

If you work for the State of Georgia

State employees aren't on Medicaid, so the answer above isn't yours. Your plan is the one the state buys for its workers: State Health Benefit Plan (SHBP). Its pharmacy benefit runs through CVS Caremark (Anthem and UnitedHealthcare options).

Only through the required 9amHealth program

Georgia's plan still pays for weight-loss prescriptions, but only through 9amHealth, a program members must use for any new weight-loss prescription. Kaiser members can't use it.

"This benefit is mandatory for any members with a new weight loss prescription and those members currently receiving coverage of any weight loss prescription drugs upon expiration of their current prior authorization period. Members enrolled in Kaiser Permanente are currently not eligible."

Georgia State Health Benefit Plan, 9amHealth Weight Management Program · source

"CVS Caremark will administer the pharmacy benefits for members and their Covered Dependent(s) enrolled in Anthem Blue Cross and Blue Shield and UnitedHealthcare Non-Medicare Advantage Plan Options."

Georgia State Health Benefit Plan, Pharmacy · source

The Wegovy criteria the SHBP criteria page links to require that "The patient has a baseline body mass index (BMI) greater than or equal to 30 kg/m2," or 27 with a weight-related condition.

CVS Caremark, Wegovy – Weight Loss Management criteria (4774-C), linked from the SHBP criteria page · source

If the appeal fails, or you cannot wait

Georgia Medicaid doesn't pay for these drugs for weight loss and names no other route, so if you're covered only by Medicaid here, paying cash may be the only way to get one. That means the whole cost, every month, with nothing counted toward your coverage.

Companies that pay this site a commission, what we found on each one's own site, and a link to check availability
CompanyWhat we found on its own site
PartnerCoreAge RxCheck availabilityCompounded semaglutide advertised at $99 a month at every dose. The page our link opens has shown $149 instead, and a consultation fee can be added that may not be refundable.
PartnerOakCheck availabilityOne flat price at every dose, with shipping and supplies included free.
PartnerGala HealthCheck availabilityOne price at every dose. The advertised rate needs a yearly subscription.
PartnerDirect MedsCheck availabilityOne price at every dose from $147, with no monthly membership. The page states its discount two ways ($150 off in the banner, up to $200 off on the tiles), so check the total at checkout.
PartnerFoundCheck availabilityBills clinician visits to your insurance where it's in network, with the drug charged separately. Its Medicare offer, brand GLP-1s from $50 a month, doesn't count toward your Part D deductible or out-of-pocket maximum, and Extra Help doesn't apply.
PartnerEdenCheck availabilitySemaglutide at $99 a month at every dose, with no membership on the page our link opens. Eden's own site pairs the same $99 with a required membership ($39 the first month, then $99), so check which one you're signing up for.

All 21 companies, with what we found on each →

Prices in those notes were read from each company's own site in August 2026 and September 2026, and they change often. Check the current number before you buy.

Where this comes from

  1. Georgia Department of Community Health, Part II Policies and Procedures for Pharmacy Services, effective July 2026 — www.mmis.georgia.gov/portal/Portals/0/StaticContent/Public/ALL/Handbooks
  2. Georgia Medicaid Fee-for-Service, Antihyperlipidemics Other Prior Authorization Summary, effective July 2021 — dch.georgia.gov/document/document/antihyperlipidemics-other-7921/downloa
  3. Georgia Medicaid Fee-for-Service, Antidiabetic Agents Prior Authorization Summary, effective July 2026 — dch.georgia.gov/document/document/antidiabetic-agents-7126v3/download
  4. Georgia Department of Community Health, Georgia Medicaid and PeachCare Preferred Drug List, effective August 2026 — dch.georgia.gov/document/document/pdl-drug-class-8-1-26/download
  5. Georgia Medicaid Fee-for-Service, Imcivree Prior Authorization Summary, effective January 2026 — dch.georgia.gov/document/document/imcivree-1126/download
  6. Georgia Department of Community Health, Part I Policies and Procedures for Medicaid and PeachCare for Kids, effective July 2026 — www.mmis.georgia.gov/portal/Portals/0/StaticContent/Public/ALL/Handbooks